Favorable Response to High-Dose Interferon-Alpha in Idiopathic Hypereosinophilic Syndrome with Restrictive Cardiomyopathy

Abstract

The idiopathic hypereosinophilic syndrome is characterized by a prolonged overproduction of eosinophils of unknown cause in addition to specific organ damage due to eosinophil-derivated protein toxicity. Its prognosis is correlated with heart involvement that results in a restrictive cardiomyopathy. This is frequently biventricular. Isolated left ventricular infiltration has rarely been reported. The authors report a case of idiopathic hypereosinophilic syndrome with cardiac involvement obliterating the left ventricular cavity with a favorable clinical outcome following a combination therapy with interferon-alpha, hydroxyurea and prednisone. Data from other studies dealing with the treatment of idiopathic hypereosinophilic syndrome with interferon- alpha are reviewed and discussed.

Get full access to this article

View all access options for this article.

References

Weller PF , Bubley GJ : The idiopathic hypereosinophilic syndrome. Blood 83:2759-2779, 1994.

Straetmans N. , Ferrant A. , Martiat P. , et al: Hypereosinophilia syndrome. Apropos of 2 cases and literature review. Acta Clin Belg 47:90-99, 1992.

Zientek DM , King DL , Dewan SJ , et al: Hypereosinophilic syndrome with rapid progression of cardiac involvement and early echocardiographic abnormalities. Am Heart J 130:1295-1298, 1995.

Chusid MJ , Dale DC , West BC , et al: The hypereosinophilic syndrome: Analysis of fourteen cases with review of literature. Medicine 54:1-27, 1975.

Rauch AE , Amyot KM , Dunn HG , et al: Hypereosinophilic syndrome and myocardial infarction in a 15-year-old . Pediatr Pathol Lab Med 17:469-486, 1997.

Coutant G. , Bletry O. , Prin L. , et al: Treatment of hypereosinophilic syndrome of myeloproliferative expression with the combination of hydrossiurea and interferon-alpha. Apropos of 7 cases. Ann Med Interne 144:243-250, 1993.

Corssmit Epm , Trip MD , Durrer MD : Loffler endomyocarditis in the idiopathic hypereosinophilic syndrome. Cardiology 91:271-276, 1999.

Lombardi C. , Rusconi C. , Faggiano P. , et al: Successful reduction of endomyocardial fibrosis in a patient with idiopathic hypereosinophilic syndrome—a case report. Angiology 46:345-351, 1995.

Schandenè L. , Roufosse F. , Lavareille A. , et al: Interferon α prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood 96:4285-4295, 2000.

10.

Bockenstedt PL , Santinga JT , Bolling SF : Alpha-interferon treatment for idiopathic hypereosinophilic syndrome. Am J Hematol 45:248-251, 1994.

11.

Esteve J. , Cervantes F. , Bosch F. , et al: Tratamiento con interferon alfa del sindrome hipereosinofilico idiopatico resistente a la terapeutica convencional. Med Clin (Barc) 106:304-306, 1996.

12.

van den Anker-Lugtemburg PJ , van't Veer MB : Alpha-interferon in a case of hypereosinophilic syndrome. Br J Haematol 77:258, 1991.

13.

Fruehauf S. , Fiehn C. , Haas R. , et al: Sustained remission of idiopathic hypereosinophilic syndrome following alpha-interferon therapy . Acta Haematol 89:91-93, 1993.

14.

Butterfield JH , Gleich GJ : Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med 121:648-653, 1994.